tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

COGT Stock Latest News

Cogent Biosciences downgraded to Hold from Buy at Needham
The FlyCogent Biosciences downgraded to Hold from Buy at Needham
11d ago
COGT
Cogent Biosciences announces updates results from SUMMIT
PremiumThe Fly
Cogent Biosciences announces updates results from SUMMIT
13d ago
COGT
Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial
PremiumThe Fly
Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial
14d ago
COGT
Cogent Biosciences price target raised to $21 from $19 at JPMorgan
PremiumThe Fly
Cogent Biosciences price target raised to $21 from $19 at JPMorgan
1M ago
COGT
Cogent Biosciences Reports Progress in Clinical Trials and Financial Standing
PremiumCompany Announcements
Cogent Biosciences Reports Progress in Clinical Trials and Financial Standing
1M ago
COGT
Cogent Biosciences reports Q3 EPS (64c), consensus (57c)
PremiumThe FlyCogent Biosciences reports Q3 EPS (64c), consensus (57c)
1M ago
COGT
COGT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
COGT Upcoming Earnings Report: What to Expect?
1M ago
COGT
Cogent selloff on ‘old news’ is ‘unwarranted,’ says Citi
Premium
The Fly
Cogent selloff on ‘old news’ is ‘unwarranted,’ says Citi
2M ago
BPMC
COGT
Cogent data has positive read-through to Blueprint, says Barclays
PremiumThe Fly
Cogent data has positive read-through to Blueprint, says Barclays
2M ago
BPMC
COGT
Cogent Biosciences down after bezuclastinib abstract released
PremiumThe Fly
Cogent Biosciences down after bezuclastinib abstract released
2M ago
COGT
Blueprint should rally on today’s Cogent data, says Oppenheimer
PremiumThe Fly
Blueprint should rally on today’s Cogent data, says Oppenheimer
2M ago
BPMC
COGT
Cogent Biosciences announces pipeline expansion into KRAS
PremiumThe Fly
Cogent Biosciences announces pipeline expansion into KRAS
2M ago
COGT
Cogent Biosciences price target raised to $15 from $13 at Citi
PremiumThe FlyCogent Biosciences price target raised to $15 from $13 at Citi
3M ago
COGT
Cogent Biosciences price target raised to $10 from $8 at Baird
Premium
The Fly
Cogent Biosciences price target raised to $10 from $8 at Baird
4M ago
COGT
Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright
Premium
The Fly
Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright
4M ago
COGT
Cogent Biosciences announces trials in patients with GIST completes enrollment
PremiumThe Fly
Cogent Biosciences announces trials in patients with GIST completes enrollment
4M ago
COGT
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
PremiumThe Fly
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
5M ago
COGT
Cogent Biosciences expects cash to fund operations into 2027
PremiumThe Fly
Cogent Biosciences expects cash to fund operations into 2027
5M ago
COGT
Cogent Biosciences announces upcoming milestones
PremiumThe Fly
Cogent Biosciences announces upcoming milestones
5M ago
COGT
Cogent Biosciences reports Q2 EPS (59c), consensus (56c)
PremiumThe FlyCogent Biosciences reports Q2 EPS (59c), consensus (56c)
5M ago
COGT
Cogent Biosciences announces FDA meeting, alignment of MS2D2
Premium
The Fly
Cogent Biosciences announces FDA meeting, alignment of MS2D2
6M ago
COGT
Cogent Biosciences announces clinical data from Part 1 of ongoing SUMMIT trial
Premium
The Fly
Cogent Biosciences announces clinical data from Part 1 of ongoing SUMMIT trial
6M ago
COGT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >